Advertisement

Topics

ImmunoMolecular Therapeutics Launches to Advance Innovative Immunotherapies for Genetically Defined Type 1 Diabetes and Other Autoimmune Diseases

08:00 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
- Founded by world class researchers from the Barbara Davis Center for Diabetes at the University of Colorado, Denver - ImmunoMolecular Therapeutics (IM Therapeutics), a company developing personalized small molecule therapi...

Other Sources for this Article

MacDougall Biomedical Communications
Amanda Houlihan or Kari Watson, 781-235-3060
ahoulihan@macbiocom.com
kwatson@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "ImmunoMolecular Therapeutics Launches to Advance Innovative Immunotherapies for Genetically Defined Type 1 Diabetes and Other Autoimmune Diseases"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...